Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pyrazinamide 200mg/5ml oral liquid
0501090N0AABFBF
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 250mg/5ml oral liquid
0501090N0AABKBK
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 275mg/5ml oral liquid
0501090N0AABUBU
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 300mg/5ml oral liquid
0501090N0AABJBJ
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 312.5mg/5ml oral liquid
0501090N0AACDCD
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 350mg/5ml oral liquid
0501090N0AABEBE
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 375mg/5ml oral liquid
0501090N0AABDBD
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 400mg/5ml oral liquid
0501090N0AABTBT
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 420mg/5ml oral liquid
0501090N0AABZBZ
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 425mg/5ml oral liquid
0501090N0AABRBR
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 430mg/5ml oral liquid
0501090N0AACBCB
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 450mg/5ml oral liquid
0501090N0AABGBG
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 490mg/5ml oral liquid
0501090N0AABVBV
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 50mg/5ml oral liquid
0501090N0AAA9A9
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 600mg/5ml oral liquid
0501090N0AABPBP
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 625mg/5ml oral liquid
0501090N0AABSBS
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 650mg/5ml oral liquid
0501090N0AACACA
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 675mg/5ml oral liquid
0501090N0AABQBQ
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 700mg/5ml oral liquid
0501090N0AACCCC
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 750mg/5ml oral liquid
0501090N0AAA8A8
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 75mg/5ml oral liquid
0501090N0AABLBL
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 850mg/5ml oral liquid
0501090N0AABWBW
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrazinamide 91mg/5ml oral liquid
0501090N0AACGCG
|
Pyrazinamide | Pyrazinamide | Infections | No data available |
|
Pyrimethamine 10mg/5ml oral suspension
0504010N0AAAIAI
|
Pyrimethamine | Pyrimethamine | Infections | No data available |
|
Pyrimethamine 25mg / Sulfadoxine 500mg tablets
0504010P0AAAAAA
|
Pyrimethamine/sulfadoxine | Pyrimethamine with sulfadoxine | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.